Megan Garlapow, PhD

All articles by Megan Garlapow, PhD

• Efgartigimod delivers rapid relief for hard-to-treat myasthenia gravis

  Most patients with generalized myasthenia gravis saw meaningful symptom improvement within four weeks of treatment with efgartigimod.

• Study reveals that MG-ADL may miss MG breathing issues

  Patient-reported breathing symptoms did not reliably match lung function test results, indicating objective testing remains essential in MG.

• Study reveals higher cancer risk in myasthenia gravis

  People with myasthenia gravis had higher rates of cancer both before and after diagnosis compared with matched controls.

• Claseprubart quickly improves symptoms in myasthenia gravis trial

  Claseprubart produced rapid and meaningful improvements in daily function and muscle strength in MG, with benefits seen as early as week 1.

• Study reveals gaps in blood testing for myasthenia gravis

  Many people with myasthenia gravis are diagnosed and treated without antibody blood tests that can help clarify the diagnosis.

• FDA approves inebilizumab for generalized myasthenia gravis

  FDA approval of inebilizumab gives adults with generalized myasthenia gravis a new treatment designed for long-lasting symptom control.

• Early thymectomy improves remission in ocular myasthenia gravis

  Patients with ocular myasthenia gravis who undergo thymectomy before generalization are more likely to achieve lasting remission.

• Older patients with MG face higher death rates from other illnesses

  Older adults with myasthenia gravis had higher overall death rates than peers without the condition, mainly due to other chronic illnesses.

• Researchers identify 2 distinct types of anti-AChR-positive myasthenia gravis

  Two biologically distinct forms of anti-AChR-positive myasthenia gravis (MG) appear to differ by sex, age and immune response.

• Mesenchymal stem cells show promise in easing MG muscle weakness

  Mesenchymal stem cells can calm immune system attacks and slow the muscle wasting seen in MG, potentially improving strength and endurance.